AEterna Zentaris, Inc. (NASDAQ: AEZS) Starts Presentation at the 2017 Marcum Microcap Conference
AEterna Zentaris (NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in developing and commercializing novel pharmaceutical therapies. The company recently completed phase 3 studies of two internally developed compounds and intends to license out certain commercial rights of internally developed products to licensees in non-U.S. territories where such out-licensing would enable the company to ensure development, registration and launch of its product candidates. For more information, visit the company's website at www.aezsinc.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users (1) access to our news aggregation and syndication servers, (2) enhanced press release services, and (3)…







